Literature DB >> 17110922

Why do we need quality-assured diagnostic tests for sexually transmitted infections?

Rosanna W Peeling1, David Mabey, Alan Herring, Edward W Hook.   

Abstract

The bacterial sexually transmitted infections (STIs) syphilis, gonorrhoea and chlamydia can all be cured with a single dose of antibiotic. Unfortunately, however, these infections often remain undiagnosed as many infected individuals have few if any symptoms. Diagnostic tests with high sensitivity and specificity are available for all three infections but, owing to their expense and the lack of laboratory capacity, most people in developing countries do not have access to these tests. There is a great need for simple, cheap diagnostic tests for STIs that can be performed at the point of care, enabling treatment to be given immediately. It is hoped that recent advances in our understanding of the pathogenesis of these infections, and the availability of the complete genome sequences for each causative organism, will lead to the development of improved point-of-care tests that will reduce the burden of these diseases in developing countries.

Entities:  

Mesh:

Year:  2006        PMID: 17110922     DOI: 10.1038/nrmicro1569

Source DB:  PubMed          Journal:  Nat Rev Microbiol        ISSN: 1740-1526            Impact factor:   60.633


  12 in total

Review 1.  Beyond "safe sex"--can we fight adolescent pelvic inflammatory disease?

Authors:  Bahaa Abu Raya; Ellen Bamberger; Nogah C Kerem; Aharon Kessel; Isaac Srugo
Journal:  Eur J Pediatr       Date:  2012-07-10       Impact factor: 3.183

2.  Microfluidics-based diagnostics of infectious diseases in the developing world.

Authors:  Curtis D Chin; Tassaneewan Laksanasopin; Yuk Kee Cheung; David Steinmiller; Vincent Linder; Hesam Parsa; Jennifer Wang; Hannah Moore; Robert Rouse; Gisele Umviligihozo; Etienne Karita; Lambert Mwambarangwe; Sarah L Braunstein; Janneke van de Wijgert; Ruben Sahabo; Jessica E Justman; Wafaa El-Sadr; Samuel K Sia
Journal:  Nat Med       Date:  2011-07-31       Impact factor: 53.440

3.  Magnetically-enabled biomarker extraction and delivery system: towards integrated ASSURED diagnostic tools.

Authors:  Westley S Bauer; Danielle W Kimmel; Nicholas M Adams; Lauren E Gibson; Thomas F Scherr; Kelly A Richardson; Joseph A Conrad; Hellen K Matakala; Frederick R Haselton; David W Wright
Journal:  Analyst       Date:  2017-05-02       Impact factor: 4.616

4.  Point-of-care test for detection of urogenital chlamydia in women shows low sensitivity. A performance evaluation study in two clinics in Suriname.

Authors:  Jannie J van der Helm; Leslie O A Sabajo; Antoon W Grunberg; Servaas A Morré; Arjen G C L Speksnijder; Henry J C de Vries
Journal:  PLoS One       Date:  2012-02-29       Impact factor: 3.240

Review 5.  Improving the Accessibility and Efficiency of Point-of-Care Diagnostics Services in Low- and Middle-Income Countries: Lean and Agile Supply Chain Management.

Authors:  Desmond Kuupiel; Vitalis Bawontuo; Tivani P Mashamba-Thompson
Journal:  Diagnostics (Basel)       Date:  2017-11-29

6.  Implementation of Point-of-Care Diagnostics in Rural Primary Healthcare Clinics in South Africa: Perspectives of Key Stakeholders.

Authors:  Tivani P Mashamba-Thompson; Ngcwalisa A Jama; Benn Sartorius; Paul K Drain; Rowan M Thompson
Journal:  Diagnostics (Basel)       Date:  2017-01-08

7.  Poor supply chain management and stock-outs of point-of-care diagnostic tests in Upper East Region's primary healthcare clinics, Ghana.

Authors:  Desmond Kuupiel; Boikhutso Tlou; Vitalis Bawontuo; Paul K Drain; Tivani P Mashamba-Thompson
Journal:  PLoS One       Date:  2019-02-27       Impact factor: 3.240

8.  Quality assessment of an interferon-gamma release assay for tuberculosis infection in a resource-limited setting.

Authors:  Nguyen T L Hang; Naoki Ishizuka; Naoto Keicho; Le T Hong; Do B Tam; Vu T X Thu; Ikumi Matsushita; Nobuyuki Harada; Kazue Higuchi; Shinsaku Sakurada; Luu T Lien
Journal:  BMC Infect Dis       Date:  2009-05-18       Impact factor: 3.090

9.  Neopterin is a cerebrospinal fluid marker for treatment outcome evaluation in patients affected by Trypanosoma brucei gambiense sleeping sickness.

Authors:  Natalia Tiberti; Veerle Lejon; Alexandre Hainard; Bertrand Courtioux; Xavier Robin; Natacha Turck; Krister Kristensson; Enock Matovu; John Charles Enyaru; Dieudonné Mumba Ngoyi; Sanjeev Krishna; Sylvie Bisser; Joseph Mathu Ndung'u; Philippe Büscher; Jean-Charles Sanchez
Journal:  PLoS Negl Trop Dis       Date:  2013-02-28

Review 10.  Chlamydia trachomatis Infection in Pregnancy: The Global Challenge of Preventing Adverse Pregnancy and Infant Outcomes in Sub-Saharan Africa and Asia.

Authors:  Kristina Adachi; Karin Nielsen-Saines; Jeffrey D Klausner
Journal:  Biomed Res Int       Date:  2016-04-06       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.